205 related articles for article (PubMed ID: 37562974)
1. EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls.
Monaco MCG; Soldan SS; Su C; Clauze A; Cooper JF; Patel RJ; Lu F; Hughes RJ; Messick TE; Andrada FC; Ohayon J; Lieberman PM; Jacobson S
Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37562974
[TBL] [Abstract][Full Text] [Related]
2. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
[TBL] [Abstract][Full Text] [Related]
3. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.
Soldan SS; Anderson EM; Frase DM; Zhang Y; Caruso LB; Wang Y; Deakyne JS; Gewurz BE; Tempera I; Lieberman PM; Messick TE
Gastric Cancer; 2021 Sep; 24(5):1076-1088. PubMed ID: 33929613
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
[TBL] [Abstract][Full Text] [Related]
5. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
6. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
Liu CD; Lee HL; Peng CW
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
[TBL] [Abstract][Full Text] [Related]
7. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells.
Xu JX; Zhang R; Huang DJ; Tang Y; Ping LQ; Huang BJ; Huang HQ; Busson P; Li J
Microbiol Spectr; 2023 Feb; 11(1):e0493222. PubMed ID: 36622166
[TBL] [Abstract][Full Text] [Related]
8. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
[TBL] [Abstract][Full Text] [Related]
9. Anti-EBNA1 IgG titre is not associated with fatigue in multiple sclerosis patients.
Fleischer M; Schuh H; Bickmann NM; Hagenacker T; Krüger K; Skripuletz T; Fiedler M; Kleinschnitz C; Pul R; Skuljec J
Neurol Neurochir Pol; 2022; 56(3):236-245. PubMed ID: 35726751
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis patient-derived spontaneous B cells have distinct EBV and host gene expression profiles in active disease.
Soldan SS; Su C; Monaco MC; Yoon L; Kannan T; Zankharia U; Patel RJ; Dheekollu J; Vladimirova O; Dowling JW; Thebault S; Brown N; Clauze A; Andrada F; Feder A; Planet PJ; Kossenkov A; Schäffer DE; Ohayon J; Auslander N; Jacobson S; Lieberman PM
Nat Microbiol; 2024 Jun; 9(6):1540-1554. PubMed ID: 38806670
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review.
Bose A; Khalighinejad F; Hoaglin DC; Hemond CC
Mult Scler Relat Disord; 2024 Apr; 84():105410. PubMed ID: 38401201
[TBL] [Abstract][Full Text] [Related]
12. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
[TBL] [Abstract][Full Text] [Related]
13. EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers.
Jiang L; Xie C; Lung HL; Lo KW; Law GL; Mak NK; Wong KL
Theranostics; 2018; 8(19):5307-5319. PubMed ID: 30555548
[TBL] [Abstract][Full Text] [Related]
14. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
Wang Z; Kennedy PG; Dupree C; Wang M; Lee C; Pointon T; Langford TD; Graner MW; Yu X
J Neuroimmune Pharmacol; 2021 Sep; 16(3):567-580. PubMed ID: 32808238
[TBL] [Abstract][Full Text] [Related]
15. Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells.
Moon SH; Park NS; Noh MH; Kim YS; Cheong SH; Hur DY
Anticancer Res; 2022 Jan; 42(1):555-563. PubMed ID: 34969765
[TBL] [Abstract][Full Text] [Related]
16. Unstable EBV latency drives inflammation in multiple sclerosis patient derived spontaneous B cells.
Soldan S; Su C; Monaco MC; Brown N; Clauze A; Andrada F; Feder A; Planet P; Kossenkov A; Schäffer D; Ohayon J; Auslander N; Jacobson S; Lieberman P
Res Sq; 2023 Feb; ():. PubMed ID: 36778367
[TBL] [Abstract][Full Text] [Related]
17. Strains of Epstein-Barr virus infecting multiple sclerosis patients.
Brennan RM; Burrows JM; Bell MJ; Bromham L; Csurhes PA; Lenarczyk A; Sverndal J; Klintenstedt J; Pender MP; Burrows SR
Mult Scler; 2010 Jun; 16(6):643-51. PubMed ID: 20350958
[TBL] [Abstract][Full Text] [Related]
18. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM.
Lanz TV; Brewer RC; Ho PP; Moon JS; Jude KM; Fernandez D; Fernandes RA; Gomez AM; Nadj GS; Bartley CM; Schubert RD; Hawes IA; Vazquez SE; Iyer M; Zuchero JB; Teegen B; Dunn JE; Lock CB; Kipp LB; Cotham VC; Ueberheide BM; Aftab BT; Anderson MS; DeRisi JL; Wilson MR; Bashford-Rogers RJM; Platten M; Garcia KC; Steinman L; Robinson WH
Nature; 2022 Mar; 603(7900):321-327. PubMed ID: 35073561
[TBL] [Abstract][Full Text] [Related]
19. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
[TBL] [Abstract][Full Text] [Related]
20. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
Pender MP; Csurhes PA; Lenarczyk A; Pfluger CM; Burrows SR
J Neurol Neurosurg Psychiatry; 2009 May; 80(5):498-505. PubMed ID: 19015225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
